Contract HHSD2002012M52805P
Genscript USA Inc · Department Of Health And Human Services · August 23, 2012
Genscript USA Inc was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on August 23, 2012 for $99,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Piscataway, NJ. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 29, 2016.
Contract details
- PIID
- HHSD2002012M52805P
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Laboratory Equipment And Supplies
- Place of performance
- Piscataway, NJ
- First action
- August 23, 2012
- Latest action
- December 29, 2016
Description
RECOMBINANT PROTEINS
Modification timeline
-
December 29, 2016Mod 1$-1.0K
-
August 23, 2012Base award$100.1K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSD2002012M52805P?
Contract HHSD2002012M52805P is a federal contract awarded to Genscript USA Inc by Department Of Health And Human Services on August 23, 2012 for $99,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 1 time since the base award.
Who won contract HHSD2002012M52805P?
Genscript USA Inc won contract HHSD2002012M52805P from Department Of Health And Human Services.
How much is contract HHSD2002012M52805P worth?
Contract HHSD2002012M52805P has obligated $99,000 to date.